These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 9798567

  • 1. Guillain-Barré syndrome: recent advances.
    Hadden RD, Hughes RA.
    Hosp Med; 1998 Jan; 59(1):55-60. PubMed ID: 9798567
    [Abstract] [Full Text] [Related]

  • 2. Rapid recovery of a child with Guillain-Barré syndrome using intravenous immunoglobulins.
    Shah M, Weinberger M.
    J La State Med Soc; 1998 Nov; 150(11):533-7. PubMed ID: 9861805
    [Abstract] [Full Text] [Related]

  • 3. Management of Guillain-Barré syndrome (GBS).
    Hahn AF.
    Baillieres Clin Neurol; 1996 Oct; 5(3):627-44. PubMed ID: 9117079
    [Abstract] [Full Text] [Related]

  • 4. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.
    Baskin E, Turkay S, Icagasioglu D, Tanzer F, Cevit O.
    Turk J Pediatr; 1996 Oct; 38(1):119-23. PubMed ID: 8819632
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Guillain-Barré syndrome: a team approach to diagnosis and treatment.
    Dematteis JA.
    Am Fam Physician; 1996 Jul; 54(1):197-200. PubMed ID: 8677835
    [Abstract] [Full Text] [Related]

  • 8. Second response to immunoglobulin in recurrent Guillain-Barré syndrome.
    Nagappan R, Barker J.
    N Z Med J; 1998 Nov 13; 111(1077):433-4. PubMed ID: 9861925
    [Abstract] [Full Text] [Related]

  • 9. [Use of intravenous immunoglobulins in Guillain-Barré syndrome].
    Ceccarelli M, Assanta N, Chiaravalloti G, Rocopou C, Caiulo VA.
    Minerva Pediatr; 1992 May 13; 44(5):237-40. PubMed ID: 1620076
    [Abstract] [Full Text] [Related]

  • 10. Guillain-Barré syndrome.
    Pemberton L.
    Nurs Times; 1992 May 13; 94(46):50-3. PubMed ID: 9923382
    [No Abstract] [Full Text] [Related]

  • 11. The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously?
    van der Meché FG.
    Ann Med Interne (Paris); 1994 May 13; 145(5):293-5. PubMed ID: 7985934
    [No Abstract] [Full Text] [Related]

  • 12. Single-dose intravenous immune globulin for treatment of Guillain-Barré syndrome.
    McGhee B, Jarjour IT.
    Am J Hosp Pharm; 1994 Jan 01; 51(1):97-9. PubMed ID: 8135270
    [No Abstract] [Full Text] [Related]

  • 13. Disorder resembling Guillain-Barré syndrome on initiation of statin therapy.
    Rajabally YA, Varakantam V, Abbott RJ.
    Muscle Nerve; 2004 Nov 01; 30(5):663-6. PubMed ID: 15389662
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Guillain-Barré syndrome.
    Winer J.
    Br J Hosp Med; 2004 Nov 01; 51(6):313. PubMed ID: 8032572
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Guillain-Barré syndrome: from the original description to the modern concepts].
    Raphael JC, Sharshar T, Bourdain F, Léger JM.
    Ann Med Interne (Paris); 1999 Jan 01; 150(1):33-41. PubMed ID: 10093660
    [Abstract] [Full Text] [Related]

  • 18. A randomized trial comparing intravenous immunoglobulin and plasma exchange in Guillain-Barré syndrome.
    Kleyweg RP, van der Meché FG, Schmitz PI.
    Transfus Sci; 1994 Dec 01; 15(4):389-92. PubMed ID: 10172508
    [No Abstract] [Full Text] [Related]

  • 19. Severe Guillain-Barré syndrome during childhood responding to intravenous gammaglobulin.
    Heaton PA.
    N Z Med J; 1992 Nov 25; 105(946):477-8. PubMed ID: 1436876
    [No Abstract] [Full Text] [Related]

  • 20. [Guillain-Barré disease: a current treatment method using immunoglobulins].
    Kleyweg RP, van der Meché FG.
    Ned Tijdschr Geneeskd; 1992 Oct 03; 136(40):1956-60. PubMed ID: 1328903
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.